Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that controls hunger and blood sugar levels. Clinical trials show patients using semaglutide lose 10–15% of their body weight over 68 weeks. PlexusDx delivers personalized semaglutide therapy tailored to your genetics and metabolism.
How Semaglutide Reduces Appetite and Promotes Weight Loss
Semaglutide activates GLP-1 receptors in your brain's appetite-control centers, triggering signals of fullness even when you eat less food. This mechanism reduces cravings and prevents the constant hunger that often derails weight loss efforts. By slowing how fast your stomach empties, semaglutide keeps you satisfied longer after meals, naturally lowering daily calorie intake without extreme restriction.
The drug also stabilizes blood sugar levels, which reduces energy crashes that typically spark overeating and food cravings. When blood glucose remains steady throughout the day, your body burns stored fat more efficiently and your metabolism stays more consistent. This dual action on hunger hormones and glucose regulation creates sustainable weight loss without the metabolic slowdown seen with diet-only approaches.
Clinical Evidence: Real Weight Loss Results from Semaglutide Trials
The STEP trials, the largest semaglutide weight loss studies, enrolled over 4,500 people across five randomized controlled trials. Participants receiving semaglutide 2.4 mg weekly lost an average of 15% of body weight, compared to 2.6% in the placebo group. Some patients achieved weight loss exceeding 20% when combined with lifestyle changes, demonstrating semaglutide's substantial impact on long-term weight management.
A two-year follow-up study found that people who maintained semaglutide therapy kept most of their weight off, while those who stopped regained weight within months. This evidence confirms that semaglutide works best as a sustained treatment rather than a short-term intervention. PlexusDx supports long-term therapy with consistent monthly pricing, so your dose can increase as your body adjusts without your costs jumping unexpectedly.
Metabolic and Cardiovascular Benefits Beyond Weight Loss
Beyond shedding pounds, semaglutide improves heart health markers that contribute to weight-related disease risk. Users experience drops in triglyceride levels, reductions in blood pressure, and improved cholesterol profiles within the first three months of treatment. These improvements occur partly from weight loss itself and partly from semaglutide's direct effects on cardiovascular function, making it beneficial for people with metabolic syndrome or prediabetes.
Semaglutide also reduces inflammation throughout the body, a key driver of chronic disease and aging. By lowering inflammatory markers and improving insulin sensitivity, semaglutide addresses the root causes of weight gain rather than just suppressing appetite. This holistic metabolic reset explains why many patients report improved energy, better sleep quality, and clearer thinking after a few weeks on the medication.
Why Genetic Testing Matters: Personalizing Your Semaglutide Response
Not everyone responds to semaglutide at the same dose or timeline because genetic variations affect how your body produces and responds to GLP-1 hormones. PlexusDx Precision Peptide Genetic Test identifies key variants in your GLP1R, GIPR, FTO, and MC4R genes that predict your personalized response to semaglutide and other peptide therapies. This genetic roadmap helps your provider optimize your starting dose, titration pace, and overall treatment strategy for maximum results.
Understanding your peptide-pathway genetics transforms weight loss from a guessing game into a precision medicine approach. The test maps 14 metabolic pathways and 150+ genetic insights related to appetite regulation, fat metabolism, and insulin function. PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first month, ensuring your semaglutide protocol is built on your unique biology, not generic dosing.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose on semaglutide?
Clinical trial participants lost 10–15% of body weight on average, with some achieving 20% or more when combining medication with healthy eating and exercise. Individual results vary based on starting weight, genetics, and lifestyle factors. PlexusDx personalizes your protocol using the Precision Peptide Genetic Test to optimize your response.
How does semaglutide work differently than diet and exercise alone?
Semaglutide directly targets brain regions controlling hunger and blood sugar regulation, making calorie restriction feel natural rather than forced. Lifestyle changes alone work for some people but typically produce 5–10% weight loss; semaglutide accelerates and deepens results. The combination of medication plus healthy habits produces superior long-term outcomes compared to either approach alone.
Is PlexusDx semaglutide the same as prescription Ozempic or Wegovy?
PlexusDx offers compounded semaglutide from licensed 503A compounding pharmacies, formulated to match clinical-grade quality and purity. Compounded medications provide the same active ingredient but at lower cost and without insurance requirements. All PlexusDx medications are HSA/FSA eligible and start at $149/month, with no membership fees.
What side effects should I expect from semaglutide?
Most users experience mild nausea, appetite suppression, or digestive changes during the first 1–2 weeks as their body adjusts. These effects typically fade as your system adapts. Serious side effects are rare but can include pancreatitis or thyroid issues; your PlexusDx provider screens for contraindications before starting treatment.
Can genetic testing predict how well semaglutide will work for me?
Yes. PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your baseline appetite regulation and metabolic flexibility. These insights help predict your dose requirements, titration timeline, and whether combination therapy might enhance results. The test costs $99 after your first month and enables truly personalized medicine.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Path to Weight Management: What Dose of Wegovy Should I Start With?
How Often Do You Inject Zepbound? A Comprehensive Guide to Zepbound Administration